MedVadis Research Alternatives & Competitors

12 companies similar to MedVadis Research — Advancing Health in the Greater Boston Area.

SYMBYX

Medical device company empowering better health with light therapy. Research-backed, ARTG...

Australia

Health Care Health and Wellness +1

Chase Pharmaceuticals

Pioneering advancements in neuropsychiatric treatment for a brighter future

11-50 Series B $28.70M

Biotechnology Health Care

Reven Pharmaceuticals

Diligently pursuing scientific innovation to exponentially improve health and well-being.

14 Series D

Westminster, United State...

Biotechnology Health Care +2

Functional Neuromodulation

Functional Neuromodulation is advancing deep brain stimulation to treat mild Alzheimer's d...

5 Series A $10.40M

Minneapolis, United State...

Health Care Platforms

Rival Readout

Competing with MedVadis Research? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

AXON Neuroscience

Independent clinical stage biotech company.

Bratislava, Slovakia

Health Care Information Technology +1

Day One Biopharmaceuticals

Cancer drug development comes of age.

190 Post-IPO Equity $687.50M

Brisbane, United States

Biopharma Biotechnology +2

Centrexion Therapeutics Corp.

We aim to relieve the suffering associated with chronic pain by creating treatments that a...

23 Venture round $229.16M

Boston, United States

Biotechnology Health Care +1

Palatin Technologies

We discover and develop novel therapeutics for patients living with inflammatory and autoi...

50 Post-IPO Equity $133.90M

Biotechnology Health Care +1

Prizm Pain Specialists

Care that changes lives

Canton, United States

Health Care Health and Wellness

Acadia Pharmaceuticals

Acadia is trailblazing breakthroughs in neuroscience to elevate life.

1028 Post-IPO Equity $811.73M

San Diego, United States

Biotechnology Health Care +1

Nocion Therapeutics, Inc.

18 Series B $111.00M

Watertown, United States

Biotechnology Health Care

NeRRe Therapeutics Ltd

Developing a breakthrough treatment for the disabling chronic cough associated with idiopa...

9 Series B $61.40M

Stevenage, United Kingdom

Biotechnology Health Care

About MedVadis Research

MedVadis Research is a healthcare startup based in the United States with a focus on advancing medical treatments through clinical research. Established in 1996 by Egilius L.H. Spierings, M.D., Ph.D., the company has conducted over 300 clinical research trials encompassing a diverse range of medical conditions.

Business keywords

Clinical Research, Medical Treatments, Alzheimer's Disease, Chronic Pain, Neuropathy, Migraine, Pediatric Migraine, Healthcare Advancements, Clinical Trials, Medical Conditions, Drug Efficacy, Medical Research, Boston Area

Frequently Asked Questions

Companies similar to MedVadis Research include SYMBYX , Chase Pharmaceuticals, Reven Pharmaceuticals, Functional Neuromodulation, AXON Neuroscience. They work in Health Care and share MedVadis Research's focus on clinical trials, alzheimer's disease and clinical research.

Bounce Watch lists 12 companies that share MedVadis Research's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around MedVadis Research: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

MedVadis Research Profile SYMBYX Alternatives Chase Pharmaceuticals Alternatives Reven Pharmaceuticals Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at MedVadis Research on 14 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.